UBS’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

UBS’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$250K	Buy	4,800 +2,100	+78%	+$107K	﹤0.01%	4968
2014 Q2	$139K	Sell	2,700 -8,400	-76%	-$379K	﹤0.01%	5567
2014 Q1	$527K	Buy	11,100 +9,600	+640%	+$491K	﹤0.01%	4167
2013 Q4	$65K	Buy	1,500 +600	+67%	+$24.8K	﹤0.01%	6624
2013 Q3	$39K	Buy	900 +300	+50%	+$12.2K	﹤0.01%	7186
2013 Q2	$21K	Buy	+600	New	+$21.1K	﹤0.01%	7842

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LRPA

L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return

UBS's XBI Position: Q3 2014 in Review

UBS increased its State Street SPDR S&P Biotech ETF (XBI) stake by 6.6% in Q3 2014, buying an estimated $4.6M and bringing the position to 1,455,717 shares worth $75.7M. The position accounts for 0.06% of the portfolio, ranked #342.

UBS first reported a position in XBI in Q2 2013 and has held it in 6 quarters since. 129 funds tracked by Wall St. Rank hold XBI as of Q3 2014.

UBS held 1,455,717 shares of State Street SPDR S&P Biotech ETF worth $75.7M as of Q3 2014.
UBS bought 90,201 State Street SPDR S&P Biotech ETF shares in Q3 2014, an estimated $4.6M.
State Street SPDR S&P Biotech ETF made up 0.06% of UBS's portfolio in Q3 2014, its #342 holding.
UBS first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 6 quarters since.
129 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.